loader image
who are we

We're on a mission to
to modernize and educate all health institutions in the diagnosis and therapy of lymphoma

In addition, SLG provides active support and assistance in the education of experts from Serbia, advocates for the standardization of diagnostic and therapeutic procedures, and members of SLG are involved in various research projects and clinical trials. An important segment of the SLG’s activities is the facilitation of local and international exchange of experiences in the treatment of lymphoma, through professional meetings and symposia.

Our main Goals

01
development

contribution to the development and improvement of lymphoma detection and treatment

02
affirmation

affirmation of an interdisciplinary approach to the diagnosis and treatment of lymphoma

03
exchange of experiences

enabling domestic and foreign exchange of experiences in the treatment of lymphoma

04
meetings

organization of professional meetings, congresses and seminars

05
participation

participation of in expert bodies in controlling the work of medical services dealing with lymphoma treatment

06
education

supporting the education of experts from Serbia and standardization of diagnostic and therapeutic procedures

“We strongly believe that constant training in the profession and the personnel involvement in scientific projects, testing of certain drugs and procedures is essential for maintaining the highest standards of healthcare.”
–  Darko Antić

So far, SLG has published multiple educational materials intended for the general population, guides for the diagnosis and treatment of lymphoma, brochures, and instructions for the early detection of lymphoma, primarily for primary healthcare physicians, as well as educational booklets for lymphoma patients and their families. One of the most significant projects of SLG is the development of an electronic registry for lymphomas.

Over the past years, there has been exceptional collaboration with leading global experts in the field of hematology and lymphoma, who served as lecturers at professional meetings.

The most significant ones include:

  1. Follicular lymphoma – Current standards and future strategies, 2008. Prof. Dr. M. Dreyling, Dept. of Medicine III, Klinikum Grosshadern, Munich
  2. New chapter in the treatment of patients with CLL, 2010. Prof. Dr. M. Trneny, Ist Dept Medicine, Charles University General Hospital
  3. Treatment strategies in advanced follicular lymphoma, 2011. Prof. Dr. Marinus H.J van Oers, Academic Medical Center Amsterdam
  4. Therapy of Hodgkin’s lymphoma, 2012. Prof. Andras Engert, University Hospital Cologne
  5. Lymphoma meeting, 2013. Prof. Dr. M. Ghielmini, Oncology Institute of Southern Switzerland
  6. Rituximab maintenance therapy in patients with FL, 2015. Prof. Dr. med. Christian Buske, Institute of Experimental Cancer Research & Department of Internal Medicine III, University Hospital Ulm

Over the past decade (2006-2016), 27 doctors defended 32 master’s theses, doctoral dissertations, subspecialty works in the field of lymphoma, and we can boast numerous participations in international congresses, domestic congresses, as well as publications in the field of lymphoproliferative diseases in domestic and international journals.

Our doctors had the opportunity to gain professional expertise abroad in the field of lymphoma (Cologne, University Clinic, AKH Clinic Vienna, Belincon Institute for Oncology).

A good team is essential

Meet SLG Team

Darko Antić

Darko Antić

Chairman
Boško Anđelić

Boško Anđelić

Secretary General
Katarina Marković

Katarina Marković

Treasurer

Board of directors:

  • Asst. Dr. Darko Antić
  • Assistant Dr. O. Marković
  • Assistant Dr. Z. Cvetkovič
  • Dr. I. Petković
  • Dr. D. Agić
  • Dr. V. Nikolić
  • Asst. Dr. Vladislava Đurašinović

Supervisor Committee:

  • Prof. Dr. Milena Todorović Balint
  • Prof. Dr. M. Radojković
  • Prim. Dr. Z. Milojević